News BioPorto A/S

Equities

Delayed Nasdaq Copenhagen Other stock markets 09:30:41 2024-06-10 am EDT			5-day change	1st Jan Change
1.626 ^DKK	-1.81%		-4.13%	-22.20%

May. 30	BioPorto A/S Appoints Niels Høy Nielsen as Member of the Executive Management Team, Effective August 1, 2024	CI
May. 30	BioPorto A/S Appoints Niels Høy Nielsen as Chief Financial Officer, Effective August 1, 2024	CI

BioPorto A/S Appoints Chief Financial Officer	May. 30	GL
BioPorto A/S Appoints Niels Høy Nielsen as Member of the Executive Management Team, Effective August 1, 2024	May. 30	CI
BioPorto A/S Appoints Niels Høy Nielsen as Chief Financial Officer, Effective August 1, 2024	May. 30	CI
First Quarter 2024: Strong growth in US sales of The NGAL Test	May. 08	GL
BioPorto A/S Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 08	CI
Bioporto A/S Provides Earnings Guidance for 2024	May. 08	CI
Resolutions of Annual Geneal Meeting	Apr. 30	GL
Grant of warrants	Apr. 23	GL
BioPorto Names New Chief Legal Officer	Apr. 10	MT
BioPorto A/S Appoints Chief Legal Officer	Apr. 10	GL
Bioporto A/S Appoints Gry Louise Husby Larsen as Chief Legal Officer and Member of the Executive Management Team, Effective as of April 15, 2024	Apr. 10	CI
New Board Candidate for the upcoming Annual Geneal Meeting	Apr. 05	GL
Bioporto A/S Announces Tonni Bülow-Nielsennot to Stand for Election	Apr. 05	CI
Notice convening the Annual General Meeting in BioPorto A/S	Apr. 04	GL
Correction: BioPorto Announces Annual Results for 2023	Apr. 04	GL
BioPorto Announces Annual Results for 2023	Apr. 04	AQ
BioPorto A/S Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 04	CI
BioPorto Makes Interim CEO Permanent	Apr. 02	MT
BioPorto appoints Peter Mørch Eriksen as permanent Group Chief Executive Officer	Apr. 02	GL
BioPorto A/S Appoints Peter Mørch Eriksen as Permanent Group CEO	Apr. 02	CI

No results for this search